(Philadelphia,
PA) - Najjia N. Mahmoud, MD, has been appointed
Assistant Professor in the Department of Surgery, Division
of Colon and Rectal Surgery, at the University of Pennsylvania
School of Medicine.
Dr. Mahmoud earned her BS degree (Summa Cum Laude) in
Microbiology and Public Health from the University of
Wisconsin. She then received her MD from Weill Medical
College of Cornell University in 1993. She did a two
year basic science research fellowship at Weill Medical
College of Cornell University while completing her residency
in Surgery at New York Presbyterian Hospital, and then
completed a fellowship in Colorectal Surgery at the
University of Minnesota.
Dr. Mahmoud's research focuses on the genetics of inherited
colorectal cancer and she has a strong clinical interest
in sphincter-preserving rectal cancer surgery, as well
as pelvic floor dysfunction/reconstruction. She is board
certified by the American Board of Surgery and the American
Board of Colon and Rectal Surgery. Dr. Mahmoud is currently
an Attending Surgeon at the Hospital of the University
of Pennsylvania.
Her accolades include the American Association of Cancer
Research Young Investigator Award, the Carl E. Christianson
Outstanding Resident Scholar Award and the Administrative
Chief Fellow Award, the latter two awarded from the
Division of Colon and Rectal Surgery at the University
of Minnesota. Dr. Mahmoud is a member of the American
Association for Cancer Research, the American College
of Surgeons Oncology Group, the American Society of
Colon and Rectal Surgeons, and the American Association
of Women Surgeons, among others. She was recently invited
to lecture at the United Ostomy Association National
Meeting in Philadelphia on colon cancer.
Dr. Mahmoud has been published in many peer-reviewed
publications including Hematology-Oncology Clinics
of North America, Cancer Research, Carcinogenesis, Surgery,
Proceedings of the American Association of Cancer Research
and Proceedings of the American Society of Colon
and Rectal Surgeons.
# # #
.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.